August 13, 2021
Japanese patch drug powerhouse Hisamitsu Pharmaceutical was slapped with a business suspension order on August 12 for falsifying data in the manufacturing process of one of the OTC products among its mainstay Salonpas series of topical anti-inflammatory analgesics. The government...read more